These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6822136)

  • 21. Antihypertensive effects of a new transdermal delivery system for clonidine (M-5041T) in spontaneously hypertensive rats.
    Ishii R; Naruse T; Tagawa T; Yamahata T; Dote S; Hamada K; Ishida T; Funabiki K; Namba K
    Arch Int Pharmacodyn Ther; 1994; 327(3):294-308. PubMed ID: 7848013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetics of clonidine and chlorthalidone following subacute administration of a fixed combination compared with a sustained release formulation of clonidine alone (author's transl)].
    Arndts D; Doevendans J; Arendt G; Rippen G
    Arzneimittelforschung; 1981; 31(11):1954-7. PubMed ID: 7198476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in blood pressure, plasma catecholamines and plasma renin activity during and after treatment with tiamenidine and clonidine.
    Hansson BG; Hökfelt B
    Br J Clin Pharmacol; 1981 Jan; 11(1):73-7. PubMed ID: 7011348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral clonidine loading for rapid control of hypertension.
    Cohen IM; Katz MA
    Clin Pharmacol Ther; 1978 Jul; 24(1):11-5. PubMed ID: 657713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonidine pharmacokinetics in pregnancy.
    Buchanan ML; Easterling TR; Carr DB; Shen DD; Risler LJ; Nelson WL; Mattison DR; Hebert MF
    Drug Metab Dispos; 2009 Apr; 37(4):702-5. PubMed ID: 19116263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of clonidine after rectal administration in children.
    Lönnqvist PA; Bergendahl HT; Eksborg S
    Anesthesiology; 1994 Nov; 81(5):1097-101. PubMed ID: 7978467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of a new transdermal clonidine, M-5041T, in healthy subjects.
    Fujimura A; Ebihara A; Shiga T; Kumagai Y; Ohashi K; Nakashima H; Kotegawa T
    J Clin Pharmacol; 1993 Dec; 33(12):1192-200. PubMed ID: 8126254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A sliding intravenous dose schedule for clonidine in hypertensive patients.
    Velasco M; Gallardo E; Plaja J; Guevara J
    Clin Pharmacol Ther; 1976 Jul; 20(1):31-5. PubMed ID: 776490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid kinetics of epidural clonidine in man.
    Glynn CJ; Jamous MA; Teddy PJ
    Pain; 1992 Jun; 49(3):361-367. PubMed ID: 1408302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of clonidine.
    Lowenthal DT
    J Cardiovasc Pharmacol; 1980; 2 Suppl 1():S29-37. PubMed ID: 6154834
    [No Abstract]   [Full Text] [Related]  

  • 31. Transdermal clonidine in the treatment of adolescent hypertension.
    Falkner B; Thanki B; Lowenthal DT
    J Hypertens Suppl; 1985 Dec; 3(4):S61-3. PubMed ID: 3868713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apparent resistance to hypotensive effect of clonidine.
    Wing LM; Reid JL; Davies DS; Dargie HJ; Dollery CT
    Br Med J; 1977 Jan; 1(6054):136-8. PubMed ID: 832037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma clonidine concentration and pharmacologic effect.
    Hogan MJ; Wallin JD; Chu LC
    Clin Pharmacol Ther; 1981 Dec; 30(6):729-34. PubMed ID: 7307423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innovative drug delivery systems in cardiovascular medicine: nifedipine-GITS and clonidine-TTS.
    Frishman WH; Sherman D; Feinfeld DA
    Cardiol Clin; 1987 Nov; 5(4):703-16. PubMed ID: 3331321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The disposition and pharmacokinetics of clonidine in patients--practical consequences.
    Frisk-Holmberg M
    Ups J Med Sci Suppl; 1980; 31():13-5. PubMed ID: 6935853
    [No Abstract]   [Full Text] [Related]  

  • 36. Clonidine twice daily in hypertension. Effects of two dosage regimens on blood pressure, side-effects and plasma clonidine concentrations.
    Lilja M; Huikuri H; Jounela AJ; Juustila HJ; Paalzow G
    Acta Med Scand; 1983; 214(2):111-7. PubMed ID: 6353878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue pharmacokinetics of clonidine in rats.
    Conway EL; Jarrott B
    J Pharmacokinet Biopharm; 1982 Apr; 10(2):187-200. PubMed ID: 7120048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition of clonidine in rats as determined by radioimmunoassay.
    Jarrott B; Spector S
    J Pharmacol Exp Ther; 1978 Oct; 207(1):195-202. PubMed ID: 702340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of plasma catecholamines and flushing by clonidine in man.
    Metz SA; Halter JB; Porte D; Robertson RP
    J Clin Endocrinol Metab; 1978 Jan; 46(1):83-90. PubMed ID: 221515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical effects of a clonidine-chlorthalidone combination in the treatment of arterial hypertension].
    Antonello A; Campanini M; Glorioso S; Borsatti A; Todesco S
    Minerva Med; 1976 Jul; 67(35):2273-81. PubMed ID: 951049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.